These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34910966)

  • 41. Vaccine hesitancy, distress, and medical mistrust in women considering or undergoing fertility treatment during the COVID-19 pandemic.
    Kassi LA; Lawson AK; Feinberg EC; Swanson A; Shah S; Pavone M
    J Assist Reprod Genet; 2022 Dec; 39(12):2767-2776. PubMed ID: 36352326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.
    Hong J; Xu XW; Yang J; Zheng J; Dai SM; Zhou J; Zhang QM; Ruan Y; Ling CQ
    J Integr Med; 2022 Jan; 20(1):34-44. PubMed ID: 34774463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 Vaccine Acceptance in a Sample From the United Arab Emirates General Adult Population: A Cross-Sectional Survey, 2020.
    Albahri AH; Alnaqbi SA; Alshaali AO; Alnaqbi SA; Shahdoor SM
    Front Public Health; 2021; 9():614499. PubMed ID: 34381748
    [No Abstract]   [Full Text] [Related]  

  • 44. Multilevel Determinants of COVID-19 Vaccine Uptake Among South Asian Ethnic Minorities in Hong Kong: Cross-sectional Web-Based Survey.
    Singh A; Lai AHY; Wang J; Asim S; Chan PS; Wang Z; Yeoh EK
    JMIR Public Health Surveill; 2021 Nov; 7(11):e31707. PubMed ID: 34653014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 vaccine hesitancy and its associated factors in Malaysia.
    Lee KW; Gew LT; Siau CS; Peh SC; Chia YC; Yacob S; Chan NN; Seow VK; Ooi PB
    PLoS One; 2022; 17(9):e0266925. PubMed ID: 36048822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sociodemographic Factors Associated with Vaccine Hesitancy in Central Texas Immediately Prior to COVID-19 Vaccine Availability.
    Litaker JR; Tamez N; Lopez Bray C; Durkalski W; Taylor R
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 vaccine hesitancy among youth.
    Willis DE; Presley J; Williams M; Zaller N; McElfish PA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5013-5015. PubMed ID: 34715003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determinants of COVID-19 vaccine hesitancy: questionnaire development and validation.
    Cvjetković S; Jeremić Stojković V; Piperac P; Djurdjević O; Bjegović-Mikanović V
    Cent Eur J Public Health; 2022 Jun; 30(2):99-106. PubMed ID: 35876598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 2020.
    Hwang SE; Kim WH; Heo J
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-8. PubMed ID: 34614382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis.
    Abbasi N; Ghadiri F; Moghadasi AN; Azimi A; Navardi S; Heidari H; Karaminia M; Sahraian MA
    Mult Scler Relat Disord; 2022 Apr; 60():103723. PubMed ID: 35276452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China.
    Akel KB; Masters NB; Shih SF; Lu Y; Wagner AL
    Hum Vaccin Immunother; 2021 Aug; 17(8):2639-2646. PubMed ID: 33769209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing Determinants of COVID-19 Vaccine Hesitancy in Nevada.
    Coughenour C; Gakh M; Sharma M; Labus B; Chien LC
    Health Secur; 2021 Nov; 19(6):592-604. PubMed ID: 34882034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
    Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
    Front Public Health; 2022; 10():846861. PubMed ID: 35462827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19 vaccine hesitancy among Chinese residents under the free vaccination policy.
    Liu H; Zhou Z; Tao X; Huang L; Zhu E; Yu L; Zhang M
    Rev Assoc Med Bras (1992); 2021 Sep; 67(9):1317-1321. PubMed ID: 34816927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults.
    Nishimi K; Neylan TC; Bertenthal D; Seal KH; O'Donovan A
    JAMA Netw Open; 2022 Apr; 5(4):e227287. PubMed ID: 35420660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parents' and caregivers' role toward childhood vaccination in Albania: assessment of predictors of vaccine hesitancy.
    Gjini E; Moramarco S; Carestia MC; Cenko F; Ylli A; Mehmeti I; Palombi L; Buonomo E
    Ann Ig; 2023; 35(1):75-83. PubMed ID: 35532052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey.
    Alibrahim J; Awad A
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccine Hesitancy and Fear of COVID-19 Among Italian Medical Students: A Cross-Sectional Study.
    Lo Moro G; Cugudda E; Bert F; Raco I; Siliquini R
    J Community Health; 2022 Jun; 47(3):475-483. PubMed ID: 35138490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 Vaccine Hesitancy and How to Address It.
    Rittle C
    Workplace Health Saf; 2022 Feb; 70(2):56-62. PubMed ID: 35073804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 Vaccine Hesitancy in Italian Adults with Marfan Syndrome: Insights from a Secondary Analysis of a Cross-Sectional Study.
    Udugampolage NS; Pini A; Magon A; Conte G; Callus E; Taurino J; Caruso R
    Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.